Company page

Longbio Pharma (suzhou) Co., Ltd. Class H

Longbio Pharma (Suzhou) Co., Ltd. Class H, trading under the ticker 1779 on the Hong Kong market, is a public company focused on biopharmaceutical development. The company is dedicated to advancing innovative therapies and improving healthcare outcomes. Longbio Pharma aims to leverage its expertise in the biopharmaceutical sector to contribute to the global healthcare landscape.